[1] Tripathy SK, Goyal T, Sen RK, et al. Management of femoral head osteonecrosis: Current concepts. Indian J Orthop. 2015;49(1):28-45.[2] Moya-Angeler J, Gianakos AL, Villa JC, et al. Current concepts on osteonecrosis of the femoral head. World J Orthop. 2015;6(8):590-601. [3] Mont MA, Cherian JJ, Sierra RJ, et al. Nontraumatic osteonecrosis of the femoral head: where do we stand today? a ten-year update. J Bone Joint Surg Am.2015;97(19): 1604-1627.[4] Weinstein RS, Hogan EA, Borrelli MJ, et al. The pathophysiological sequence of glucocorticoid-induced osteonecrosis of the femoral head in male mice. Endocrinology.2017;158(11):3817-3831. [5] Bai R, Feng W, Liu WL,et al. Roles ofosteocyte apoptosis in steroid-induced avascular necrosis of the femoral head. Exp Ther Med. 2017;14(1): 367-372.[6] Zhu L, Chen J, Zhang J, et al. Parathyroid hormone (PTH) induces autophagy to protect osteocyte cell survival from dexamethasone damage. Med Sci Monit.2017;23:4034-4040. [7] Li X, Li YS, Li LJ, et al. Overactivated autophagy contributes to steroid-induced avascular necrosis of the femoral head. Exp Ther Med. 2017;14(1):367-372. [8] Gardeniers JW. A new international classification of osteonecrosis of the ARCO Committee on terminology and classification. J Jpn Orthop Assoc.1992; 66:18-20.[9] Ryosuke Y,Takuaki Y,Goro M, et al. MRI-detected double low-intensity bands in osteonecrosis of the femoral head. J Orthop Sci.2011;16(4): 471-475.[10] Wang XL, Liu Y, Wang XM, et al. The role of 99mTc-annexin V apoptosis scintigraphy in visualizing early stage glucocorticoid-induced femoral head osteonecrosis in the rabbit. Biomed Res Int. 2016;2016:7067259. [11] 李挺松,肖增明,黄秋嫔,等.降脂抗凝联合作用对兔激素性股骨头坏死骨细胞凋亡的影响[J].中国医科大学学报, 2014,43(5): 441-445.[12] 李卫哲,李景南,郑得志,等.降脂、抗凝药物预防激素所致股骨头骨细胞坏死、凋亡及对BcL-2表达的影响[J].中华创伤骨科杂志, 2004,6(9):1078-1079.[13] Wang C, Peng J, Lu S. Summary of the various treatments for osteonecrosis of the femoral head by mechanism: A review. Exp Ther Med. 2014; 8(3):700-706.[14] 吉万波,刘冠虹,刘锦涛,等.股密葆方对大鼠激素性股骨头坏死脂质代谢影响的实验研究[J].中国骨质疏松杂志, 2016,22(12): 1580-1584. [15] 彭小明,李挺松,肖增明,等. 降脂联合抗凝与单纯降脂干预对兔激素性股骨头坏死的影响对比分析[J].广西医科大学学报, 2016, 33(05):766-769.[16] 胡敏,赵宏斌,董锡亮,等.普伐他汀修复激素性股骨头坏死兔模型的超微结构评价[J].中国组织工程研究, 2010, 14(37): 6861-6864.[17] 李挺松,肖增明.普伐他汀对兔激素性股骨头坏死骨细胞凋亡的干预研究[J].广西医科大学学报, 2006, 23(2): 210-212. [18] Wu X, Yang S, Duan D, et al.Experimental osteonecrosis induced by a combination of low-dose lipopolysaccharide and high-dose methylprednisolone in rabbits. Joint Bone Spine. 2008;75(5): 573-578.[19] 强辉,冯敏,刘慧通,等.三七皂苷对激素性股骨头坏死早期细胞凋亡的影响及其机制[J].西安交通大学学报(医学版), 2018,39(1): 111-115.[20] 张晨,李苗,马骏,等.Wnt/β-catenin信号通路在大鼠早期激素性股骨头缺血性坏死中的作用机制研究[J].中国修复重建外科杂志,2016,30(06):661-668.[21] 卓金伟,俞松,甘永桥,等. Wnt/β-catenin信号通路在幼兔激素性股骨头缺血坏死模型中的表达及意义[J].中华小儿外科杂志, 2017,38(6):470-474.[22] Kerachian MA, Harvey EJ, Cournoyer D, et al. A rat model of early stage osteonecrosis induced by glucocorticoids. J Orthop Surg Res. 2011; 6(1): 62-68.[23] 赵振群,刘万林,龚瑜林,等.骨髓造血细胞DNA氧化损伤与骨细胞凋亡: 在早期激素性股骨头坏死中的表现[J].中国组织工程研究, 2015,19(11): 1652-1657.[24] 高吉建,李彪,龚跃昆.激素性股骨头坏死与他汀类药物的修复治疗作用[J].中国组织工程研究与临床康复, 2011,15(43): 8124-8127.[25] Ajmal M, Matas AJ, Kuskowski M, et al. Does statin usage reduce the risk of corticosteroid-related osteonecrosis in renal transplant population? Orthop Clin North Am.2009; 40(2): 235-239. |